Improved outcomes with leadless vs. single-chamber transvenous pacemaker in haemodialysis patients.

ABSTRACT:

Aims

Cardiac conduction disorders are common in haemodialysis patients, with a relatively high rate of pacemaker implantations. Pacemaker-related complications, especially lead infections and central venous stenosis, pose significant challenges in this population. This study aims to compare single-chamber leadless pacemaker to single-chamber transvenous pacemakers in terms of survival and related complications in haemodialysis patients.

Methods and results

This retrospective study included adult haemodialysis patients who received a first single-chamber transvenous or leadless pacemaker between January 2017 and December 2020. Data were obtained from the French national REIN registry matched to the national health databases (Système National des Données de Santé). Propensity

SUBMITTER: Panico A 

PROVIDER: S-EPMC11542626 | biostudies-literature | 2024 Nov

REPOSITORIES: biostudies-literature